Navigation Links
FDA Warns Against Use of Diarrhea Drug From El Salvador
Date:9/19/2012

WEDNESDAY, Sept. 19 (HealthDay News) -- Consumers should not use a drug product called Intestinomicina -- marketed as a treatment for infectious diarrhea and acute gastrointestinal infections -- because it contains an ingredient that can cause serious and potentially deadly problems, the U.S. Food and Drug Administration warns.

People who bought Intestinomicina should immediately stop taking it and consult with a health care provider, the FDA said in a safety alert issued Tuesday.

Intestinomicina, which is made in El Salvador, contains a prescription drug ingredient called chloramphenicol. Earlier this year, in July, oral forms of chloramphenicol were taken off the U.S. market due to the risk of serious health problems.

The most dangerous threat associated with oral chloramphenicol is bone marrow toxicity, which occurs when the body does not produce enough red blood cells, white blood cells and/or platelets, the FDA noted in a news release.

While some types of bone marrow toxicity are reversible, in certain rare cases it can lead to death. Those at greatest risk for serious injury or death are patients with anemia, low white or red blood cell count, or decreased blood platelets.

Intestinomicina's label also lists antibacterial ingredients including neomycin, which is an antibiotic often found in topical medications, and sulfonamides (sulfa drugs). Neomycin and sulfa drugs can cause a variety of reactions, ranging from rashes and hives to severe and life-threatening reactions, the FDA said.

In addition, Intestinomicina may interact with other medications people may be taking, the FDA pointed out in the news release.

Intestinomicina -- made by Laboratorios Lopez -- is sold in tablet and liquid form by international grocery stores in the United States that feature South and Central American specialty foods and products.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diarrhea and its treatment.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, Sept. 18, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dont cut lifesaving ICDs during financial crisis, ESC warns
2. US risks losing out to Asia in medical research, U-M team warns
3. Extreme Heat Biggest Weather Killer, Expert Warns
4. CDC Warns of Another Emerging Tick-Borne Threat
5. The US Drug Watchdog Now Warns Time Could Run Out to Get Women Yaz or Yasmin Birth Control Pill Users Identified if they Suffered a Heart Attack Stroke or a Embolism
6. New device warns workers of high levels of airborne metals in minutes rather than weeks
7. FDA Warns of Fake Version of ADHD Drug Adderall
8. Immigrant women giving birth in Spain suffer great stress, a study warns
9. Vall d’Hebron, VHIO and SOLTI head up an international dream team against breast cancer
10. New gene offers hope for preventive medicine against fractures
11. Drug combination against NRAS-mutant melanoma discovered
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Warns Against Use of Diarrhea Drug From El Salvador 
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology: